IMRA Research and Charts

IMRA - Imara Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2023-08-07 (Delayed quote data 2025-07-11)

Last 51.56	Change ⇑ +0.04 (+0.08%)	Volume 4,787
	Open 51.57	High 51.72	Low 51.40

8EMA (Daily) 50.43	40EMA (Daily) 48.94	50EMA (Daily) 47.66	STO (Daily) 90.643	MACD Hist (Daily) 0.608
8EMA (Weekly) 48.924	40EMA (Weekly) 28.53	50EMA (Weekly) 24.95	STO (Weekly) 65.741	MACD Hist (Weekly) -1.292


Company Profile
Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.